J2777 Injection, faricimab-svoa, 0.1mg
J-Codes
Also known as: faricimab, vabysmo
Injection of faricimab-svoa (Vabysmo), 0.1 milligrams, a bispecific antibody inhibiting angiopoietin-2 and VEGF-A for retinal diseases.
Clinical Context
Administered by intravitreal injection for treatment of age-related macular degeneration (AMD) and diabetic macular edema (DME).
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.